Article
Surgery
Ayesha P. Ng, Yas Sanaiha, Syed Shahyan Bakhtiyar, Shayan Ebrahimian, Corynn Branche, Peyman Benharash
Summary: This study compared the hospitalization costs and clinical outcomes between robotic-assisted surgery and laparoscopic approaches for major abdominal operations, and found that the costs of robotic-assisted surgery were higher but did not result in significant clinical benefits.
Article
Cardiac & Cardiovascular Systems
Yunpeng Zhao, Lei Shan, Chuanliang Peng, Bo Cong, Xiaogang Zhao
Summary: This study retrospectively reviewed 214 consecutive patients who underwent minimally invasive oesophagectomy, showing that the operation time, bleeding volume, and postoperative mortality decreased significantly after 20 patients, and the rise point for node dissection was observed at patient 57. In the short term, patients who underwent mature thoracoscopic-laparoscopic oesophagectomy had better outcomes compared to those who underwent an open procedure.
JOURNAL OF CARDIOTHORACIC SURGERY
(2021)
Article
Gastroenterology & Hepatology
Eileen Morgan, Isabelle Soerjomataram, Anna T. Gavin, Mark J. Rutherford, Piers Gatenby, Aude Bardot, Jacques Ferlay, Oliver Bucher, Prithwish De, Gerda Engholm, Christopher Jackson, Serena Kozie, Alana Little, Bjorn Moller, Lorraine Shack, Hanna Tervonen, Vicky Thursfield, Sally Vernon, Paul M. Walsh, Ryan R. Woods, Christian Finley, Neil Merrett, Dianne L. O'Connell, John Reynolds, Freddie Bray, Melina Arnold
Summary: The survival of esophageal cancer has significantly improved over the past 20 years in participating countries, especially for adenocarcinoma, younger age groups, and the first year after diagnosis. Australia and Ireland consistently showed higher survival rates. However, further advancements in early detection and treatment are needed for specific groups and patients with squamous cell carcinoma.
Article
Cardiac & Cardiovascular Systems
Brendan T. Heiden, Joshua D. Mitchell, Eric Rome, Varun Puri, Bryan F. Meyers, Su-Hsin Chang, Benjamin D. Kozower
Summary: Compared with VATS, RAL is not cost-effective for lung cancer lobectomy at lower willingness-to-pay thresholds. However, several factors including lower robotic instrument costs, shorter operating room times, lower conversion rates, shorter lengths of stay, higher hospital volumes, and improved quality of life may drive RAL to emerge as the more cost-effective approach for minimally invasive lung cancer resection.
ANNALS OF THORACIC SURGERY
(2022)
Article
Pharmacology & Pharmacy
Meiyu Wu, Shuxia Qin, Liting Wang, Chongqing Tan, Ye Peng, Xiaohui Zeng, Xia Luo, Lidan Yi, Xiaomin Wan
Summary: This study evaluated the cost-effectiveness of pembrolizumab plus chemotherapy as first-line therapy for advanced oesophageal cancer from the perspective of the Chinese healthcare system. The results showed that this treatment approach was not cost-effective compared to placebo plus chemotherapy.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Multidisciplinary Sciences
Felix Machleid, Jenessa Ho-Wrigley, Ameera Chowdhury, Anita Paliah, Ho Lam Poon, Elena Pizzo
Summary: This study compared the cost-utility of robot-assisted radical cystectomy (RARC) and open radical cystectomy (ORC) for bladder cancer patients. The results did not provide a definitive recommendation for RARC, as the incremental cost-effectiveness ratio (ICER) did not fall below the threshold. Further research is needed to justify the intervention and determine its cost-effectiveness.
Article
Surgery
Philip H. Pucher, Min Hae Park, David A. Cromwell, Tom C. Crosby, Betsan Thomas, Nigel Trudgill, Muhammad Wahedally, Nick Maynard, James A. Gossage
Summary: National population data for patients with oesophagogastric cancer in England and Wales between 2012 and 2020 were analyzed. Despite failures in early diagnosis and increasingly comorbid patients, improvements in surgical and oncological outcomes were noted. Regression analysis showed that more recent care and higher unit volume were significantly associated with better surgical outcomes.
BRITISH JOURNAL OF SURGERY
(2023)
Review
Medicine, General & Internal
Ritchie T. J. Geitenbeek, Thijs A. Burghgraef, Mark Broekman, Bram P. A. Schop, Tom G. F. Lieverse, Roel Hompes, Klaas Havenga, Maarten Postma, Esther C. J. Consten
Summary: This systematic review aims to provide an overview of the costs in patients with rectal cancer following different surgical techniques, and discuss the impact on future healthcare costs.
Article
Oncology
Berit Sunde, Mats Lindblad, Marlene Malmstrom, Jakob Hedberg, Pernilla Lagergren, Magnus Nilsson
Summary: A Swedish study found that patients with esophageal cancer reported low function scores and severe symptoms 1 year after diagnosis, regardless of receiving curative or palliative management. Patients who underwent surgery had more issues with diarrhea, while those treated with chemoradiotherapy had more frequent dysphagia.
Article
Nutrition & Dietetics
Poorna Anandavadivelan, Asif Johar, Pernilla Lagergren
Summary: This study aimed to assess whether the BMI adjusted weight loss grading system (WLGS) before and after surgery can predict cancer cachexia in oesophageal cancer patients. The results showed that higher grades of both preoperative and postoperative WLGS were predictive of cancer cachexia-related physical decline after one year of surgery. Additionally, both preoperative and postoperative WLGS were also predictive of inadequate information on weight loss and increased worry regarding eating and weight loss.
EUROPEAN JOURNAL OF CLINICAL NUTRITION
(2022)
Article
Oncology
Ville E. J. Sirvio, Jari V. Rasanen, Joonas H. Kauppila
Summary: The prognosis of esophageal cancer has improved in Finland over the last 30 years, with significant increases in survival rates for patients undergoing esophagectomy. However, the prognosis for patients not undergoing surgery remains poor.
Article
Oncology
A. I. Damanakis, F. Gebauer, A. Stapper, H. A. Schloesser, M. Ghadimi, T. Schmidt, L. M. Schiffmann, H. Fuchs, T. Zander, A. Quaas, C. J. Bruns, W. Schroeder
Summary: By analyzing 715 patients with oesophageal squamous cell carcinoma (SCC) or adenocarcinoma (AC) who received neoadjuvant treatment, it was found that combining histopathologic regression and nodal status can improve the prediction of survival after treatment.
BRITISH JOURNAL OF CANCER
(2023)
Article
Surgery
Edward Young, Ravi Vissapragada, Norma B. Bulamu, Devinder Philip Raju, Christopher Richard McDonald
Summary: The study examined the costs associated with robotic surgical systems and found that in the base case scenario, the cost per patient was AU$26,424. Results showed that increasing the percentage of robotic-assisted cases can reduce costs, open conversion rates, and length of stay.
ANZ JOURNAL OF SURGERY
(2021)
Article
Gastroenterology & Hepatology
Soo Min Noh, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, In Ja Park, Seok-Byung Lim, Jeong-Sik Byeon
Summary: This retrospective observational study analyzed the cost of endoscopic resection and surgical resection for submucosal colorectal cancer. The study found that endoscopic resection had a lower total cumulative cost and comparable oncologic outcomes as surgical resection. Therefore, endoscopic resection can be considered a cost-effective option for initial treatment of submucosal colorectal cancer.
DISEASES OF THE COLON & RECTUM
(2023)
Article
Surgery
Alexandra M. Adams, Bradley N. Reames, Robert W. Krell
Summary: By analyzing data from patients with pancreatic cancer who underwent surgery, it was found that palliative bypass procedures for pancreatic cancer have not become safer over time, with high 30-day mortality and complication rates.
AMERICAN JOURNAL OF SURGERY
(2023)